Lexology September 17, 2024
With every major advancement in the field of aging biology, humankind is one step closer to turning back the clock and restoring our youth. In our previous longevity blog, we highlighted several novel therapeutics that have shown promise in extending lifespan and increasing healthspan (the amount of time spent in life free of disease) in animal models. If science is advancing us towards the “fountain of youth”, why are there no FDA approved anti-aging therapies on the market? In this second installment of our “Longevity Series”, we discuss regulatory, scientific, and practical hurdles that scientists in the longevity community must overcome to bring their new drugs to the general population.
According to the CFR – Code of Federal Regulations Title...
Today's Sponsors
Today's Sponsor